Site Map

• Home
• Experience
  • Multinational Companies
  • Public Companies
  • Private Companies
  • Research & Academic Institutions
  • Hospitals & Physicians
  • Startups & Entrepreneurs
• Professionals
  • Kevin Buckley, J.D.
  • Suzanne Baycan, B.S.
  • Nach Davé, M.S., R.Ph.
  • Elie Gendloff, Ph.D., J.D.
  • Erika Hamer, B.A.
  • Dmitry Kryndushkin, Ph.D.
  • Mark Malek, J.D.
  • Steven Stupp, Ph.D.
  • Neil Thompson, M.S.
  • Foreign Associates
• Intellectual Property
  • Patent Preparation & Prosecution
    • Artificial Intelligence Patents
    • Biotechnology Patents
    • Chemistry & Chemical Engineering Patents
    • Medical Device Patents
    • Pharmaceutical Patents
    • Pharmaceutical Lifecycle Management
    • Convergence Technology Patents
  • National Phase Entry (PCT)
  • IP Litigation
  • IP Opinions & Counseling
  • IP Resources
    • Patent Rights Overview
    • International Patent Law
    • U.S. Patent Law
      • Patent Eligibility
      • Novelty
      • Obviousness
      • Written Description
      • Enablement
    • Anatomy of a U.S. Patent
      • Utility Patent
      • Design Patent
      • Plant Patent
    • Trademark Law
    • Copyright Law
    • Trade Secrets
    • Know How
    • Intangible Assets
• Regulatory Services
  • Dossier Submissions
  • Quality Compliance (ISO)
  • CE Mark - MDR Services
  • Digital Health
  • Hatch-Waxman & Biosimilars
  • Labeling, Advertising & Promotion
  • Reimbursement & Health Economics
• Technology Transactions
  • Intellectual Property Agreements
  • Intellectual Property Due Diligence
  • Intellectual Property Valuation
  • Regulatory Agreements
  • Regulatory Due Diligence
  • Business Agreements
  • Transactional Due Diligence
  • Corporate Strategy
• About Us
  • The Advantages of Hiring Our Firm
  • Successes
  • Client Testimonials
  • Careers
  • Diversity
  • Contact
• Site Map
• Legal Notices
• Payments